Pasithea Therapeutics Corp's total assets for Q were $26.12M, a decrease of -14.81% from the previous quarter. KTTA total liabilities were $2.72M for the fiscal quarter, a 19.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.